novo nordisk's semaglutide failed to slow alzheimer's disease progression glp1 #drugdevelopment #clinicaldevelopment #alzheimersdisease #alzheimersresearch #curealzheimersdisease #patientsarewaiting #hope #neuroscience #cns | Ian Laquian Novo reports 2 trial failures

Ian Larios (Chef/Nutritionist): Hired to manage his diet, preparing, for instance, high-protein, air-fried meals while on tour Mental Health/Therapy: Jelly Roll focused heavily on overcoming food addiction by treating it similarly to his past drug addictions, using mental work to reduce "food noise"

Canadian guide covering dosing, protocols, and where to buy in 2026

These de-identified data environments were specifically designed to enable data access and analysis without requiring Institutional Review Board oversight, approval, or exemption confirmation

Maryland Trim Clinic (MTC) in Laurel, MD To avoid confusion, MTC here refers to Maryland Trim Clinic, not medullary thyroid carcinoma, which is a separate medical term mentioned in GLP-1 medication warnings

Raghu, 2016

95% CI, 0.19-0.68)